TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/1/22 17:28 | 3/31/22 | MNPR | Monopar Therapeutics | DE | Health | Drug | Pharmaceutical Preparations | Mazar Andrew Paul | IL | DO | Chief Sc | M.d | 0 | 0.00 | 0 | 2 | 0 | 4,300 | D | ||||||||||||||
1/4/22 14:49 | 1/1/22 | MNPR | Monopar Therapeutics | DE | Health | Drug | Pharmaceutical Preparations | Mazar Andrew Paul | IL | DO | Chief Sc | M.d | 0 | 0.00 | 0 | 2 | 0 | 4,299 | D | ||||||||||||||
1/4/22 14:40 | 12/31/21 | MNPR | Monopar Therapeutics | DE | Health | Drug | Pharmaceutical Preparations | Mazar Andrew Paul | IL | DO | Chief Sc | M.d | 0 | 0.00 | 0 | 2 | 0 | 4,298 | D | ||||||||||||||
10/1/21 19:31 | 9/30/21 | MNPR | Monopar Therapeutics | DE | Health | Drug | Pharmaceutical Preparations | Mazar Andrew Paul | IL | DO | Chief Sc | M.d | 0 | 0.00 | 0 | 2 | 0 | 4,297 | D | ||||||||||||||
7/2/21 17:11 | 6/30/21 | MNPR | Monopar Therapeutics | DE | Health | Drug | Pharmaceutical Preparations | Mazar Andrew Paul | IL | DO | Chief Sc | M.d | 0 | 0.00 | 0 | 3 | 0 | 4,295 | D | ||||||||||||||
1/5/21 17:38 | 1/1/21 | MNPR | Monopar Therapeutics | DE | Health | Drug | Pharmaceutical Preparations | Mazar Andrew Paul | IL | DO | Chief Sc | M.d | 0 | 0.00 | 0 | 2 | 0 | 4,418 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |